| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/14/2010 | WO2010003568A1 Topical composition for the treatment of actinic keratosis |
| 01/14/2010 | WO2010003465A2 A drug powder for inhalation administration and a process thereof |
| 01/14/2010 | WO2010003430A1 Formulations with polycarbohydratesiloxane coatings, their production and use |
| 01/14/2010 | WO2010003308A1 The use of nitric oxide and signal transduction system thereof in preparing medicaments for targeted therapy of malignant tumors |
| 01/14/2010 | WO2010003287A1 THE USE OF POTASSIUM 2-(α- HYDROXYPENTYL) BENZOATE IN THE MANUFACTURE OF MEDICAMENTS FOR PREVENTING AND/OR TREATING SENILE DEMENTIA |
| 01/14/2010 | WO2010003268A2 Methods and compositions for enhanced delivery of macromolecules |
| 01/14/2010 | WO2009144569A3 Hydrogel capable of containing and conveying cells |
| 01/14/2010 | WO2009138208A8 Process for manufacturing chewing gum having a coating layer, and the chewing gum obtainable by said process |
| 01/14/2010 | WO2009136336A3 Medical microbubble generation |
| 01/14/2010 | WO2009135852A3 Encapsulation of biologically active agents |
| 01/14/2010 | WO2009134347A3 Sulfoalkyl ether cyclodextrin compositions |
| 01/14/2010 | WO2009132050A3 Auris formulations for treating otic diseases and conditions |
| 01/14/2010 | WO2009118589A3 Orally disintegrating compositions of rhein or diacerein |
| 01/14/2010 | WO2009099650A4 Treatment of bladder diseases with a tlr7 activator |
| 01/14/2010 | WO2009094273A3 Compositions and methods for adoptive and active immunotherapy |
| 01/14/2010 | WO2009085832A3 Manufacture of tablet |
| 01/14/2010 | WO2009050189A3 Multipart capsule for staged release of one or more substances |
| 01/14/2010 | WO2009044380A3 Formulations containing orlistat particles having controlled particle size |
| 01/14/2010 | WO2009034453A3 Method for the immobilization of bioactive molecules within a polymeric substrate resistant to the stomach acids as oral drug delivery system |
| 01/14/2010 | US20100010479 Dosage control apparatus |
| 01/14/2010 | US20100010418 Electrically activated gel array for transdermal drug delivery |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010104 Semi-Solid Delivery Vehicle and Pharmaceutical Compositions |
| 01/14/2010 | US20100009914 Method of protecting sensitive molecules from a photo-polymerizing environment |
| 01/14/2010 | US20100009007 Non-covalent modification of microparticles and process of preparing same |
| 01/14/2010 | US20100009006 Tasteless nutritional supplement containing free amino acids |
| 01/14/2010 | US20100009005 Novel acetysalicylic acid formulations |
| 01/14/2010 | US20100009004 Intraorally rapidly disintegrating tablet |
| 01/14/2010 | US20100009003 Pharmaceutical preparation to be dispersed before administration |
| 01/14/2010 | US20100009001 Novel nanoparticles |
| 01/14/2010 | US20100009000 Granule and preparation method thereof |
| 01/14/2010 | US20100008999 Compositions for oral adminstration of active principles requiring masking of taste |
| 01/14/2010 | US20100008998 Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof |
| 01/14/2010 | US20100008997 Compositions and methods for treating asthma and other lung disorders |
| 01/14/2010 | US20100008996 Inhalative and instillative use of semifluorinated alkanes as an active substance carrier in the intrapulmonary area |
| 01/14/2010 | US20100008995 Processes for preparing pharmaceutical compositions |
| 01/14/2010 | US20100008994 Electrospun structures and methods for forming and using same |
| 01/14/2010 | US20100008993 Compositions and Methods for Increasing Bioavailability of Topical Ophthalmic Drugs |
| 01/14/2010 | US20100008992 Treatment of disc degenerative disease and compositions for same |
| 01/14/2010 | US20100008991 Transdermal estrogen device and delivery |
| 01/14/2010 | US20100008990 Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs |
| 01/14/2010 | US20100008989 Process for manufacture of gelatin solutions and products thereof |
| 01/14/2010 | US20100008988 Tablet compositions of amine polymers |
| 01/14/2010 | US20100008987 Modified Release Pharmaceutical Composition of Bupropion Hydrochloride |
| 01/14/2010 | US20100008986 Pharmaceutical compositions comprising sumatriptan and naproxen |
| 01/14/2010 | US20100008985 Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| 01/14/2010 | US20100008984 Solid dispersions comprising tacrolimus |
| 01/14/2010 | US20100008983 Rasagiline soft gelatin capsules |
| 01/14/2010 | US20100008982 Non-covalent complexes of bioactive agents with starch for oral delivery |
| 01/14/2010 | US20100008981 Methods and sequences to suppress primate huntington gene expression |
| 01/14/2010 | US20100008980 Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer |
| 01/14/2010 | US20100008979 Delivery of therapeutic agents to the bone |
| 01/14/2010 | US20100008978 Nanoparticles effective for internalization into cells |
| 01/14/2010 | US20100008977 Liposomally encapsulated hybrid adenovirus-semliki forest virus (sfv) vectors carrying rnai constructs and therapeutic genes for use against cancer targets and other diseases |
| 01/14/2010 | US20100008976 Medical Use of N-Phenylpropenoyl-Amino Acid Derivatives and Related Compounds |
| 01/14/2010 | US20100008975 Predicting response to a HER inhibitor |
| 01/14/2010 | US20100008974 Transdermal granisetron |
| 01/14/2010 | US20100008973 Compositions And Methods For Wound Healing |
| 01/14/2010 | US20100008972 Film for active ingredients dermal and transdermal administration |
| 01/14/2010 | US20100008971 Chewing composition comprising coenzyme q10 |
| 01/14/2010 | US20100008967 Bioactive scaffolds |
| 01/14/2010 | US20100008966 Medical Devices and Methods for Delivery of Nucleic Acids |
| 01/14/2010 | US20100008965 Biocompatible medical products having enhanced anti-thrombogenic properties |
| 01/14/2010 | US20100008964 Isolated stromal cells and methods of using the same |
| 01/14/2010 | US20100008956 Composition and combinations of carboxylic acid losartan in dosage forms |
| 01/14/2010 | US20100008937 Targeted delivery to leukocytes using non-protein carriers |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | US20100008868 Sustained remission of atopic dermatitis |
| 01/14/2010 | US20100008867 Method of treatment and pharmaceutical compositions |
| 01/14/2010 | US20100008866 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 01/14/2010 | US20100008865 Mixture of iron and copper salts masking metallic taste |
| 01/14/2010 | DE102008045152A1 Künstliche Sauerstoffträger und ihre Verwendung Artificial oxygen carriers and their use |
| 01/14/2010 | DE102008033662A1 Pharmacological dosage form, in the form of capsules or tablets, comprises two active magnetic parts that are arranged in unstable condition to each other and are biocompatible |
| 01/14/2010 | DE102008032594A1 Transfektionslösung Transfection |
| 01/14/2010 | DE10013942B4 Verfahren zum Herstellen von Arzneimitteln aus Ausgangsstoffen der traditionellen chinesischen Medizin A method for producing medicines from raw materials of traditional Chinese medicine |
| 01/14/2010 | CA2730391A1 Delivery of dry formulations of octreotide |
| 01/14/2010 | CA2730325A1 Composition |
| 01/14/2010 | CA2730321A1 Process for preparing microparticles |
| 01/14/2010 | CA2730292A1 Degradable microcapsules |
| 01/14/2010 | CA2730178A1 Methods and compositions for enhanced delivery of macromolecules |
| 01/14/2010 | CA2730154A1 The application of potassium 2-(1-hydroxypentyl)-benzoate (d1-phpb) for the prevention and treatment of alzheimer's disease |
| 01/14/2010 | CA2730112A1 Directly pressed aliskiren tablets |
| 01/14/2010 | CA2730108A1 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 01/14/2010 | CA2730093A1 Resorbable membrane implanting methods for reducing adhesions |
| 01/14/2010 | CA2730085A1 Functional micelles for hard tissue targeted delivery of chemicals |
| 01/14/2010 | CA2730060A1 Exine shells |
| 01/14/2010 | CA2730008A1 Eprosartan compositions |
| 01/14/2010 | CA2729979A1 Pharmaceutical compositions comprising 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
| 01/14/2010 | CA2729974A1 Topical composition for the treatment of actinic keratosis |
| 01/14/2010 | CA2729950A1 Transdermal estrogen device and delivery |
| 01/14/2010 | CA2729948A1 Tacrolimus for improved treatment of transplant patients |
| 01/14/2010 | CA2728856A1 Composition and method of preparation of release systems for constant (zero-order) release of active agents |
| 01/14/2010 | CA2728213A1 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/14/2010 | CA2728190A1 Device and method for making solid beads |
| 01/14/2010 | CA2728176A1 Drug loaded polymeric nanoparticles and methods of making and using same |
| 01/14/2010 | CA2726314A1 Electrostatically charged nasal application multipurpose products and method |
| 01/14/2010 | CA2726311A1 Electrostatically charged multi-acting nasal application, product, and method |
| 01/13/2010 | EP2143800A1 Formulations of lycopene and uses thereof |
| 01/13/2010 | EP2143736A1 Hydroxyalkyl starch derivatives |
| 01/13/2010 | EP2143730A2 Modified peptides and their use for the treatment of autoimmune diseases |